# Rapid7, Inc.: financial statements, quarterly RPD · Nasdaq · CIK 1560327 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rpd.md) · [Financials](/companies/rpd/financials.md) · [Filings](/companies/rpd/filings.md) · [Insiders](/companies/rpd/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rpd/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [199](/filings/0001560327-24-000106.md) | [205 d](/filings/0001560327-26-000008.md) | [205](/filings/0001560327-25-000034.md) | [208](/filings/0001560327-25-000050.md) | [215](/filings/0001560327-25-000062.md) | [216 d](/filings/0001560327-26-000008.md) | [210](/filings/0001560327-26-000033.md) | [214](/filings/0001560327-26-000044.md) | [218](/filings/0001560327-25-000062.md) | [217 d](/filings/0001560327-26-000008.md) | [210](/filings/0001560327-26-000033.md) | [211](/filings/0001560327-26-000044.md) | | Cost of revenue | $m | [57.8](/filings/0001560327-24-000106.md) | [60.1 d](/filings/0001560327-26-000008.md) | [61.0](/filings/0001560327-25-000034.md) | [61.0](/filings/0001560327-25-000050.md) | [63.2](/filings/0001560327-25-000062.md) | [65.9 d](/filings/0001560327-26-000008.md) | [59.5](/filings/0001560327-26-000033.md) | [63.1](/filings/0001560327-26-000044.md) | [65.0](/filings/0001560327-25-000062.md) | [67.5 d](/filings/0001560327-26-000008.md) | [64.7](/filings/0001560327-26-000033.md) | [65.5](/filings/0001560327-26-000044.md) | | Gross profit | $m | [141](/filings/0001560327-24-000106.md) | [145 d](/filings/0001560327-26-000008.md) | [144](/filings/0001560327-25-000034.md) | [147](/filings/0001560327-25-000050.md) | [151](/filings/0001560327-25-000062.md) | [150 d](/filings/0001560327-26-000008.md) | [151](/filings/0001560327-26-000033.md) | [151](/filings/0001560327-26-000044.md) | [153](/filings/0001560327-25-000062.md) | [150 d](/filings/0001560327-26-000008.md) | [145](/filings/0001560327-26-000033.md) | [145](/filings/0001560327-26-000044.md) | | Research and development | $m | [40.2](/filings/0001560327-26-000008.md) | [40.0](/filings/0001560327-26-000008.md) | [41.4](/filings/0001560327-26-000008.md) | [40.4](/filings/0001560327-26-000008.md) | [45.0](/filings/0001560327-26-000008.md) | [46.3 d](/filings/0001560327-26-000008.md) | [47.9](/filings/0001560327-26-000033.md) | [47.2](/filings/0001560327-26-000044.md) | [46.9](/filings/0001560327-25-000062.md) | [48.6 d](/filings/0001560327-26-000008.md) | [48.4](/filings/0001560327-26-000033.md) | [47.1](/filings/0001560327-26-000044.md) | | Operating income | $m | [(16.0)](/filings/0001560327-24-000106.md) | [7.4 d](/filings/0001560327-26-000008.md) | [9.7](/filings/0001560327-25-000034.md) | [5.2](/filings/0001560327-25-000050.md) | [12.8](/filings/0001560327-25-000062.md) | [7.3 d](/filings/0001560327-26-000008.md) | [(0.1)](/filings/0001560327-26-000033.md) | [3.5](/filings/0001560327-26-000044.md) | [5.9](/filings/0001560327-25-000062.md) | [2.3 d](/filings/0001560327-26-000008.md) | [(0.6)](/filings/0001560327-26-000033.md) | [3.0](/filings/0001560327-26-000044.md) | | Interest expense | $m | [56.5](/filings/0001560327-23-000076.md) | [2.7 d](/filings/0001560327-24-000021.md) | [2.7](/filings/0001560327-24-000050.md) | [2.7](/filings/0001560327-25-000050.md) | [2.8](/filings/0001560327-25-000062.md) | [2.8 d](/filings/0001560327-26-000008.md) | [2.7](/filings/0001560327-26-000033.md) | [2.6](/filings/0001560327-26-000044.md) | [2.6](/filings/0001560327-25-000062.md) | [2.6 d](/filings/0001560327-26-000008.md) | [2.5](/filings/0001560327-26-000033.md) | [2.5](/filings/0001560327-26-000044.md) | | Income tax | $m | [2.1](/filings/0001560327-24-000106.md) | [(4.1) d](/filings/0001560327-26-000008.md) | [8.9](/filings/0001560327-25-000034.md) | [0.5](/filings/0001560327-25-000050.md) | [3.0](/filings/0001560327-25-000062.md) | [3.5 d](/filings/0001560327-26-000008.md) | [2.7](/filings/0001560327-26-000033.md) | [2.0](/filings/0001560327-26-000044.md) | [(0.5)](/filings/0001560327-25-000062.md) | [2.6 d](/filings/0001560327-26-000008.md) | [0.7](/filings/0001560327-26-000033.md) | [(0.2)](/filings/0001560327-26-000044.md) | | Net income | $m | [(77.2)](/filings/0001560327-26-000008.md) | [19.1](/filings/0001560327-26-000008.md) | [1.4](/filings/0001560327-26-000008.md) | [6.5](/filings/0001560327-26-000008.md) | [15.4](/filings/0001560327-26-000008.md) | [2.2 d](/filings/0001560327-26-000008.md) | [2.1](/filings/0001560327-26-000033.md) | [8.3](/filings/0001560327-26-000044.md) | [9.8](/filings/0001560327-25-000062.md) | [3.1 d](/filings/0001560327-26-000008.md) | [1.1](/filings/0001560327-26-000033.md) | [6.1](/filings/0001560327-26-000044.md) | | Diluted EPS | $ per share | [(1.26)](/filings/0001560327-26-000008.md) | [0.26](/filings/0001560327-26-000008.md) | [0.02](/filings/0001560327-26-000008.md) | [0.09](/filings/0001560327-26-000008.md) | [0.21](/filings/0001560327-26-000008.md) | not reported | [0.03](/filings/0001560327-26-000033.md) | [0.13](/filings/0001560327-26-000044.md) | [0.15](/filings/0001560327-25-000062.md) | not reported | [0.02](/filings/0001560327-26-000033.md) | [0.09](/filings/0001560327-26-000044.md) | | Basic EPS | $ per share | [(1.26)](/filings/0001560327-26-000008.md) | [0.31](/filings/0001560327-26-000008.md) | [0.02](/filings/0001560327-26-000008.md) | [0.10](/filings/0001560327-26-000008.md) | [0.24](/filings/0001560327-26-000008.md) | not reported | [0.03](/filings/0001560327-26-000033.md) | [0.13](/filings/0001560327-26-000044.md) | [0.15](/filings/0001560327-25-000062.md) | not reported | [0.02](/filings/0001560327-26-000033.md) | [0.09](/filings/0001560327-26-000044.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [183](/filings/0001560327-24-000106.md) | [214](/filings/0001560327-26-000008.md) | [199](/filings/0001560327-25-000034.md) | [237](/filings/0001560327-25-000050.md) | [223](/filings/0001560327-25-000062.md) | [335](/filings/0001560327-26-000008.md) | [291](/filings/0001560327-26-000033.md) | [261](/filings/0001560327-25-000050.md) | [131](/filings/0001560327-25-000062.md) | [247](/filings/0001560327-26-000044.md) | [343](/filings/0001560327-26-000033.md) | [426](/filings/0001560327-26-000044.md) | | Current assets | $m | [536](/filings/0001560327-23-000076.md) | [634](/filings/0001560327-25-000021.md) | [626](/filings/0001560327-24-000050.md) | [674](/filings/0001560327-24-000093.md) | [673](/filings/0001560327-24-000106.md) | [786](/filings/0001560327-26-000008.md) | [733](/filings/0001560327-25-000034.md) | [755](/filings/0001560327-25-000050.md) | [635](/filings/0001560327-25-000062.md) | [737](/filings/0001560327-26-000044.md) | [900](/filings/0001560327-26-000033.md) | [931](/filings/0001560327-26-000044.md) | | Total assets | $m | [1,399](/filings/0001560327-23-000076.md) | [1,505](/filings/0001560327-25-000021.md) | [1,488](/filings/0001560327-24-000050.md) | [1,527](/filings/0001560327-24-000093.md) | [1,575](/filings/0001560327-24-000106.md) | [1,652](/filings/0001560327-26-000008.md) | [1,645](/filings/0001560327-25-000034.md) | [1,649](/filings/0001560327-25-000050.md) | [1,666](/filings/0001560327-25-000062.md) | [1,726](/filings/0001560327-26-000044.md) | [1,720](/filings/0001560327-26-000033.md) | [1,744](/filings/0001560327-26-000044.md) | | Current liabilities | $m | [508](/filings/0001560327-23-000076.md) | [570](/filings/0001560327-25-000021.md) | [524](/filings/0001560327-24-000050.md) | [579](/filings/0001560327-24-000093.md) | [574](/filings/0001560327-24-000106.md) | [630](/filings/0001560327-26-000008.md) | [589](/filings/0001560327-25-000034.md) | [556](/filings/0001560327-25-000050.md) | [535](/filings/0001560327-25-000062.md) | [575](/filings/0001560327-26-000044.md) | [1,155](/filings/0001560327-26-000033.md) | [1,160](/filings/0001560327-26-000044.md) | | Total liabilities | $m | [1,561](/filings/0001560327-23-000076.md) | [1,624](/filings/0001560327-25-000021.md) | [1,575](/filings/0001560327-24-000050.md) | [1,580](/filings/0001560327-24-000093.md) | [1,581](/filings/0001560327-24-000106.md) | [1,634](/filings/0001560327-26-000008.md) | [1,592](/filings/0001560327-25-000034.md) | [1,558](/filings/0001560327-25-000050.md) | [1,539](/filings/0001560327-25-000062.md) | [1,572](/filings/0001560327-26-000044.md) | [1,545](/filings/0001560327-26-000033.md) | [1,547](/filings/0001560327-26-000044.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(162)](/filings/0001560327-24-000106.md) | [(118)](/filings/0001560327-26-000008.md) | [(86.4)](/filings/0001560327-25-000050.md) | [(52.6)](/filings/0001560327-25-000062.md) | [(5.1)](/filings/0001560327-25-000062.md) | [17.7](/filings/0001560327-26-000044.md) | [52.7](/filings/0001560327-26-000044.md) | [90.4](/filings/0001560327-26-000044.md) | [127](/filings/0001560327-25-000062.md) | [155](/filings/0001560327-26-000044.md) | [175](/filings/0001560327-26-000044.md) | [197](/filings/0001560327-26-000044.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [3.7 d](/filings/0001560327-24-000106.md) | [63.5 d](/filings/0001560327-26-000008.md) | [31.1](/filings/0001560327-26-000008.md) | [32.9 d](/filings/0001560327-26-000008.md) | [44.0 d](/filings/0001560327-26-000008.md) | [63.8 d](/filings/0001560327-26-000008.md) | [29.8](/filings/0001560327-26-000033.md) | [47.5 d](/filings/0001560327-26-000044.md) | [39.0 d](/filings/0001560327-25-000062.md) | [37.6 d](/filings/0001560327-26-000008.md) | [39.8](/filings/0001560327-26-000033.md) | [37.0 d](/filings/0001560327-26-000044.md) | | Capital expenditure | $m | [0.3 d](/filings/0001560327-24-000106.md) | [0.4 d](/filings/0001560327-26-000008.md) | [0.6](/filings/0001560327-25-000034.md) | [0.3 d](/filings/0001560327-25-000050.md) | [1.3 d](/filings/0001560327-25-000062.md) | [1.2 d](/filings/0001560327-26-000008.md) | [1.4](/filings/0001560327-26-000033.md) | [0.9 d](/filings/0001560327-26-000044.md) | [4.1 d](/filings/0001560327-25-000062.md) | [1.2 d](/filings/0001560327-26-000008.md) | [2.1](/filings/0001560327-26-000033.md) | [1.2 d](/filings/0001560327-26-000044.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [58.7](/filings/0001560327-23-000076.md) | [59.9](/filings/0001560327-24-000050.md) | [60.5](/filings/0001560327-24-000093.md) | [61.1](/filings/0001560327-24-000106.md) | [74.0](/filings/0001560327-25-000034.md) | [74.3](/filings/0001560327-25-000050.md) | [74.5](/filings/0001560327-25-000062.md) | [64.2](/filings/0001560327-26-000033.md) | [64.7](/filings/0001560327-26-000044.md) | [65.2](/filings/0001560327-25-000062.md) | [66.9](/filings/0001560327-26-000033.md) | [67.9](/filings/0001560327-26-000044.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 67,400,640 at 2026-08-03, from the cover of the [10-Q filed 2026-08-10](/filings/0001560327-26-000044.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.